Industry-leading sustainability strategy earns Clario silver rating with EcoVadis
Clinical trial technology company outperforms all published competitor scores
PHILADELPHIA, PA – October 19, 2022 – Clario, a technology company that delivers the leading endpoint solutions for decentralized (DCT), hybrid and site-based clinical trials, today announced it received a silver sustainability rating from EcoVadis, a global business sustainability rating organization that assesses businesses across the global supply chain. Clario first began evaluating its sustainability performance with the external assessment platform in 2021 with a baseline score of 41, increasing its score to 66 in just one year.
“We are incredibly proud of the work we have done to improve our sustainability practices over the past year,” said Otis Johnson, Ph.D., Chief Diversity, Inclusion, and Sustainability Officer at Clario. “At a time with doing business should be synonymous with sustainable, ethical practices, it is an honor for our efforts to have this recognition of our work in these areas from such a prestigious organization as EcoVadis.”
EcoVadis assesses more than 100,000 companies worldwide. Clario tracks its sustainability progress against its competitors and now ranks in the top 90th percentile for the industry, outperforming all published competitor scores. It also outperformed industry competitors rated by EcoVadis in the four critical measures of sustainable procurement, ethics, labor and human rights and environment. Driving the significant year-on-year improvement were:
Sustainable Procurement:
- Created a global supplier diversity program and updated supplier sustainability code of conduct
- Trained buyers on social and environmental issues
Ethics:
- Implemented more robust whistleblower procedures
- Created a robust ESG reporting dashboard and transparently disclosed initiatives in inaugural ESG report
Labor and Human Rights:
- Trained employees on various labor and human rights topics from diversity, equity and inclusion to employee health and safety
- Implemented programs for vulnerable groups (ERGs, outreach, wellness)
Environment:
- Switched to 100% renewable energy in the Estenfeld office
- Improved data collection for GHG emissions (actual vs. spend data)
“This rating is an enormous honor, as it demonstrates the hard work we have done to get here. We will continue to strive toward continuously improving and reaching a gold sustainability rating,” said Sharon Gregory, Director of Sustainability at Clario.
For more information on Clario’s commitment to sustainable business practices, read our ESG report here.
About Clario
Clario is a leading provider of endpoint data solutions to the clinical trials industry, generating high-quality clinical evidence for our pharmaceutical, biotech, and medical device partners. We offer comprehensive evidence generation solutions that combine eCOA, cardiac solutions, medical imaging, precision motion, and respiratory endpoints.
For more than 50 years, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have supported over 26,000 clinical trials in more than 100 countries. Our global team of science, technology, and operational experts have supported over 60% of all FDA drug approvals since 2012.
For more information, go to Clario.com or follow us on LinkedIn.
Media Contact:
David Malley
Director of Brand, Content Strategy, and Communications
[email protected]